Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine plus midazolam versus pethidine plus midazolam for conscious sedation during ERCP
2006-002495-18Phase 4Completed
- Sponsor
- Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ketamine, midazolam and pethidine in biliary disease (2 arms), sponsored by Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust. Primary endpoints: Recruitment target / pilot completion, Safety and effectiveness of sedation and 1 more. Started Oct 2006; status: completed.
02
Drugs
ketaminemidazolampethidine
03
Conditions
biliary disease
Beyond the preview
Go deeper on 2006-002495-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002495-18.